William D. Humphries - 05 Jun 2025 Form 4 Insider Report for Aclaris Therapeutics, Inc. (ACRS)

Role
Director
Signature
/s/ Matthew Rothman, Attorney-in-Fact
Issuer symbol
ACRS
Transactions as of
05 Jun 2025
Net transactions value
$0
Form type
4
Filing time
09 Jun 2025, 16:20:18 UTC
Previous filing
21 Jun 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Humphries William D. Director C/O ACLARIS THERAPEUTICS, INC., 701 LEE ROAD, SUITE 103, WAYNE /s/ Matthew Rothman, Attorney-in-Fact 09 Jun 2025 0001674278

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRS Common Stock Options Exercise +4,793 +17% 33,525 06 Jun 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACRS Stock Option (Right to Buy) Award $0 +42,350 $0.000000 42,350 05 Jun 2025 Common Stock 42,350 $1.56 Direct F2, F3
transaction ACRS Restricted Stock Units Award $0 +11,580 $0.000000 11,580 05 Jun 2025 Common Stock 11,580 Direct F1, F3, F4
transaction ACRS Restricted Stock Units Options Exercise $0 -4,793 -100% $0.000000 0 06 Jun 2025 Common Stock 4,793 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
F2 The shares subject to this stock option will vest in twelve equal monthly installments commencing on July 5, 2025, subject to the Reporting Person's Continuous Service (as defined in the Plan) through each such vesting date.
F3 This grant was made pursuant to the issuer's tenth amended and restated non-employee director compensation policy.
F4 The shares underlying these restricted stock units will vest in one installment on June 5, 2026, subject to the Reporting Person's Continuous Service (as defined in the Plan) as of such date.
F5 The shares underlying these restricted stock units vested on June 6, 2025.